In this video, Vittoria Bellato speaks with Franco Marinello about the latest technological advancements in, and patient selection for, sacral nerve stimulation, and the recent publication of the SANLARS Trial.
May's Paper of the Month looks at a study to develop a disease-specific measurement instrument that can accurately measure QoL for patients with cryptoglandular anal fistula.
In a recently published study in the Diseases of the Colon & Rectum, a cohort of researchers executed a prospective, single-arm study to assess the safety and efficacy of RD2-Ver.02, an autologous whole blood product - in a flowable form - for the treatment of anal fistulas.